United States Pharmaceuticals

Arcus Biosciences Inc (RCUS)

Track

Arcus Biosciences witnessed fifteen insider trading transactions over the past ninety days, totaling approximately 6.99 million dollars in sales. President Juan Jaen executed multiple planned and proposed divestments. These activities occurred alongside a 15.1% stock price increase and a positive earnings report, with shares currently trading near their annual peak.
Ticker: RCUS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Arcus Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 10 Jul 2026
Value US$3,948,194.95 | Price 489.46 | Shares 95,810 (+39.8%)
Planned sale 10 Jul 2026
Value US$4,083,747.74 | Price 378.18 | Shares 99,913 (-48.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-10 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
95,810 +39.8%
489.46
US$3,948,195 		95,810 +39.8% 489.46 US$3,948,195
2026-07-13 2026-07-10 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
99,913 -48.2%
378.18
US$4,083,748 		99,913 -48.2% 378.18 US$4,083,748
2026-07-13 2026-07-09 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
64,289 -48.0%
341.68
US$739,619 		64,289 -48.0% 341.68 US$739,619
2026-07-09 2026-07-09 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
25,000
29.96
US$749,000 		25,000 29.96 US$749,000
2026-06-24 2026-06-24 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
50,000
28.80
US$1,440,000 		50,000 28.80 US$1,440,000
2026-06-24 2026-06-24 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
6,431 -0.7%
29.66
US$190,740 		6,431 -0.7% 29.66 US$190,740
2026-06-24 2026-06-23 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
1,697 -0.2%
28.06
US$47,620 		1,697 -0.2% 28.06 US$47,620
2026-06-24 2026-06-23 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
14,067 -1.5%
27.69
US$389,480 		14,067 -1.5% 27.69 US$389,480
2026-06-24 2026-06-22 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
9,236 -1.0%
27.03
US$249,661 		9,236 -1.0% 27.03 US$249,661
2026-06-22 2026-06-22 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
25,000
27.23
US$680,750 		25,000 27.23 US$680,750
2026-06-22 2026-06-22 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
25,000
27.23
US$680,750 		25,000 27.23 US$680,750
2026-06-01 2026-06-01 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,562 -6.1%
25.77
US$66,024 		2,562 -6.1% 25.77 US$66,024
2026-06-01 2026-06-01 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
2,562
25.34
US$64,921 		2,562 25.34 US$64,921
2026-05-12 2026-05-11 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
7,763 -8.4%
25.63
US$198,966 		7,763 -8.4% 25.63 US$198,966
2026-05-11 2026-05-11 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
7,763
25.63
US$198,966 		7,763 25.63 US$198,966
2026-05-06 2026-05-06 PrS Proposed sale
3.5
JENNIFER JARRETT

Officer

Officer
77,793
24.60
US$1,914,032 		77,793 24.60 US$1,914,032
2026-04-23 2026-04-23 PrS Proposed sale
3.5
JENNIFER JARRETT

Officer

Officer
53,826
25.20
US$1,356,562 		53,826 25.20 US$1,356,562
2026-04-08 2026-04-08 PrS Proposed sale
3.5
JENNIFER JARRETT

Officer

Officer
70,000
22.57
US$1,579,592 		70,000 22.57 US$1,579,592
2026-01-07 2026-01-05 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
100 -0.0%
23.20
US$2,320 		100 -0.0% 23.20 US$2,320
2026-01-07 2026-01-05 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
2,053 -0.2%
22.34
US$45,864 		2,053 -0.2% 22.34 US$45,864
2026-01-07 2026-01-05 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
29,670 -3.1%
21.34
US$633,158 		29,670 -3.1% 21.34 US$633,158
2026-01-05 2026-01-05 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
31,823
21.77
US$692,787 		31,823 21.77 US$692,787
2026-01-02 2025-12-31 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
6,552 -8.8%
23.38
US$153,186 		6,552 -8.8% 23.38 US$153,186
2025-12-18 2025-12-18 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
4,343
22.28
US$96,762 		4,343 22.28 US$96,762
2025-12-18 2025-12-18 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
4,343 -19.0%
22.25
US$96,614 		4,343 -19.0% 22.25 US$96,614
2025-12-18 2025-12-17 S Sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,113 -8.5%
22.16
US$46,823 		2,113 -8.5% 22.16 US$46,823
2025-12-18 2025-12-17 PlS Planned sale
3.7
ROSEN TERRY J

Chief Executive Officer

Executive Director
25,744 -1.2%
22.16
US$570,474 		25,744 -1.2% 22.16 US$570,474
2025-12-18 2025-12-17 S Sale
3.8
Jaen Juan C.

President

Officer
9,983 -2.8%
22.16
US$221,218 		9,983 -2.8% 22.16 US$221,218
2025-12-18 2025-12-17 S Sale
1.9
Markus Richard

Chief Medical Officer

Officer
4,494 -6.4%
22.16
US$99,585 		4,494 -6.4% 22.16 US$99,585
2025-12-18 2025-12-17 S Sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
5,960 -7.4%
22.16
US$132,071 		5,960 -7.4% 22.16 US$132,071
2025-12-18 2025-12-17 S Sale
3.1
Tang Carolyn C.

General Counsel

Officer
6,810 -5.2%
22.16
US$150,906 		6,810 -5.2% 22.16 US$150,906
2025-12-18 2025-12-17 S Sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
9,983 -4.9%
22.16
US$221,218 		9,983 -4.9% 22.16 US$221,218
2025-12-18 2025-12-16 S Sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,376 -8.7%
21.88
US$51,997 		2,376 -8.7% 21.88 US$51,997
2025-12-18 2025-12-16 PlS Planned sale
3.7
ROSEN TERRY J

Chief Executive Officer

Executive Director
28,947 -1.3%
21.88
US$633,485 		28,947 -1.3% 21.88 US$633,485
2025-12-18 2025-12-16 S Sale
3.8
Jaen Juan C.

President

Officer
11,225 -3.1%
21.88
US$245,651 		11,225 -3.1% 21.88 US$245,651
2025-12-18 2025-12-16 S Sale
1.9
Markus Richard

Chief Medical Officer

Officer
5,052 -6.7%
21.88
US$110,559 		5,052 -6.7% 21.88 US$110,559
2025-12-18 2025-12-16 S Sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
6,702 -7.7%
21.88
US$146,669 		6,702 -7.7% 21.88 US$146,669
2025-12-18 2025-12-16 PlS Planned sale
3.1
Tang Carolyn C.

General Counsel

Officer
7,658 -5.5%
21.88
US$167,590 		7,658 -5.5% 21.88 US$167,590
2025-12-18 2025-12-16 S Sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
11,225 -5.2%
21.88
US$245,651 		11,225 -5.2% 21.88 US$245,651
2025-12-15 2025-12-16 PrS Proposed sale
1.9
Richard Markus

Officer

Officer
10,000
21.90
US$219,000 		10,000 21.90 US$219,000
2025-12-15 2025-12-16 PrS Proposed sale
3.1
Carolyn Tang

Officer

Officer
15,000
21.90
US$328,500 		15,000 21.90 US$328,500
2025-12-15 2025-12-16 PrS Proposed sale
1.9
Alexander Azoy

Officer

Officer
5,000
21.90
US$109,500 		5,000 21.90 US$109,500
2025-12-15 2025-12-16 PrS Proposed sale
3.5
Jennifer Jarrett

Officer

Officer
22,000
21.90
US$481,800 		22,000 21.90 US$481,800
2025-12-15 2025-12-16 PrS Proposed sale
3.5
Robert C. Goeltz, II

Officer

Officer
14,000
21.90
US$306,600 		14,000 21.90 US$306,600
2025-12-15 2025-12-16 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
22,000
21.90
US$481,800 		22,000 21.90 US$481,800
2025-12-15 2025-12-16 PrS Proposed sale
3.7
Terry Rosen, Ph.D.

Officer; Director

Executive Director
55,000
21.90
US$1,204,500 		55,000 21.90 US$1,204,500
2025-12-05 2025-12-04 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
82,997 -8.0%
24.71
US$2,050,599 		82,997 -8.0% 24.71 US$2,050,599
2025-12-04 2025-12-04 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
82,997
25.26
US$2,096,504 		82,997 25.26 US$2,096,504
2025-12-01 2025-11-26 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
1,900 -6.5%
26.00
US$49,400 		1,900 -6.5% 26.00 US$49,400
2025-11-26 2025-11-26 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
1,900
24.28
US$46,132 		1,900 24.28 US$46,132
2025-11-26 2025-11-26 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
5,000
25.00
US$125,000 		5,000 25.00 US$125,000
2025-11-26 2025-11-26 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
5,000 -5.4%
25.00
US$125,000 		5,000 -5.4% 25.00 US$125,000
2025-11-19 2025-11-18 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
5,050 -0.5%
19.75
US$99,738 		5,050 -0.5% 19.75 US$99,738
2025-11-19 2025-11-17 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
7,836 -0.7%
20.71
US$162,307 		7,836 -0.7% 20.71 US$162,307
2025-11-19 2025-11-17 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
37,114 -3.4%
20.23
US$750,720 		37,114 -3.4% 20.23 US$750,720
2025-11-17 2025-11-17 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
50,000
19.99
US$999,500 		50,000 19.99 US$999,500
2025-11-12 2025-11-07 PlS Planned sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
50,291 -19.0%
18.97
US$954,066 		50,291 -19.0% 18.97 US$954,066
2025-11-03 2025-10-30 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
4,314 -0.4%
20.32
US$87,650 		4,314 -0.4% 20.32 US$87,650
2025-10-30 2025-10-30 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
1,173
20.19
US$23,683 		1,173 20.19 US$23,683
2025-10-30 2025-10-29 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
800 -0.1%
22.04
US$17,635 		800 -0.1% 22.04 US$17,635
2025-10-30 2025-10-29 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
29,365 -2.6%
21.53
US$632,167 		29,365 -2.6% 21.53 US$632,167
2025-10-30 2025-10-29 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
47,675 -4.1%
20.49
US$976,832 		47,675 -4.1% 20.49 US$976,832
2025-10-30 2025-10-28 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
19,019 -1.6%
20.19
US$383,944 		19,019 -1.6% 20.19 US$383,944
2025-10-29 2025-10-28 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
5,000 -5.1%
20.00
US$100,000 		5,000 -5.1% 20.00 US$100,000
2025-10-28 2025-10-28 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
100,000
19.88
US$1,988,000 		100,000 19.88 US$1,988,000
2025-10-28 2025-10-28 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
5,000
20.00
US$100,000 		5,000 20.00 US$100,000
2025-10-28 2025-10-28 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
5,000
20.00
US$100,000 		5,000 20.00 US$100,000
2025-10-08 2025-10-08 PlS Planned sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
37,792 -15.0%
15.05
US$568,611 		37,792 -15.0% 15.05 US$568,611
2025-10-08 2025-10-06 PlS Planned sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
12,500 -5.5%
14.54
US$181,801 		12,500 -5.5% 14.54 US$181,801
2025-10-06 2025-10-06 PrS Proposed sale
3.5
Jennifer Jarrett

Officer

Officer
100,583
13.35
US$1,342,783 		100,583 13.35 US$1,342,783
2025-09-30 2025-09-29 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,831 -9.4%
13.00
US$36,803 		2,831 -9.4% 13.00 US$36,803
2025-09-29 2025-09-29 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
2,831
12.84
US$36,350 		2,831 12.84 US$36,350
2025-09-05 2025-09-05 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
1,579
11.56
US$18,253 		1,579 11.56 US$18,253
2025-09-05 2025-09-05 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
1,579 -5.0%
11.88
US$18,758 		1,579 -5.0% 11.88 US$18,758
2025-02-27 2025-02-27 B Purchase
0.7
KANEKO YASUNORI
Non-Executive Director
20,000 +238.1%
10.06
US$201,200 		20,000 +238.1% 10.06 US$201,200
Explore more

More insider trading research around Arcus Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America